Washington Trust Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Sell
796
-324
-29% -$111K 0.02% 197
2026
Q1
$394K Sell
1,120
-101
-8% -$36K 0.03% 169
2025
Q4
$399K Buy
1,221
+31
+3% +$9.83K 0.03% 161
2025
Q3
$336K Buy
1,190
+7
+0.6% +$2.03K 0.03% 172
2025
Q2
$330K Buy
1,183
+16
+1% +$4.53K 0.03% 161
2025
Q1
$363K Sell
1,167
-238
-17% -$70.3K 0.03% 149
2024
Q4
$366K Buy
1,405
+70
+5% +$20.8K 0.03% 149
2024
Q3
$430K Buy
1,335
+127
+11% +$41.5K 0.04% 137
2024
Q2
$377K Buy
1,208
+9
+0.8% +$2.64K 0.03% 140
2024
Q1
$341K Buy
1,199
+9
+0.8% +$2.63K 0.03% 141
2023
Q4
$343K Sell
1,190
-171
-13% -$46.6K 0.03% 144
2023
Q3
$366K Hold
1,361
0.04% 138
2023
Q2
$302K Sell
1,361
-21
-2% -$4.87K 0.03% 147
2023
Q1
$334K Sell
1,382
-8
-0.6% -$1.96K 0.03% 142
2022
Q4
$365K Buy
1,390
+7
+0.5% +$1.88K 0.04% 132
2022
Q3
$312K Buy
1,383
+8
+0.6% +$1.94K 0.03% 160
2022
Q2
$334K Buy
1,375
+23
+2% +$5.64K 0.03% 158
2022
Q1
$327K Buy
1,352
+14
+1% +$3.22K 0.02% 187
2021
Q4
$300K Buy
+1,338
New +$282K 0.02% 207

Other funds holding AMGN

Washington Trust Advisors's AMGN Position: Q2 2026 in Review

Washington Trust Advisors reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $111K and leaving 796 shares worth $288K. The position accounts for 0.02% of the portfolio, ranked #197.

Washington Trust Advisors first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $430K in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Washington Trust Advisors held 796 shares of Amgen worth $288K as of Q2 2026.
  • Washington Trust Advisors sold 324 Amgen shares in Q2 2026, an estimated $111K.
  • Amgen made up 0.02% of Washington Trust Advisors's portfolio in Q2 2026, its #197 holding.
  • Washington Trust Advisors first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Amgen position peaked at $430K in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.